Moreover, immunofluorescence detection of tumor-infiltrated CD8+ T cells, as in the mouse model in Figure 3A, confirmed lower JunD protein levels in CD8+ TILs after anti–PD-1 treatment, which were upregulated after DP therapy (Supplemental Figure 14, C–F). This evidence concerns the gene PDCD1 and neoplasm.